Amira originally studied Business before gaining an MPharm degree from the University of Hertfordshire (UH) and awards including the JOEL medal and GPhC award. Amira earned her PhD (UH) on developing spectroscopic and chemometric models to detect New Psychoactive Substances (NPS), culminating publications and the JPAG Geoffrey Phillips award. Whilst at UH, Amira joined the Propharmace pre-registration training team as the Education and Development Manager. Amira became a Lecturer in Pharmaceutical Chemistry (UH), progressing to a Senior Lecturer and the MPharm First Year Lead while gaining her FHEA status. In 2019, Amira joined Swansea University as a Senior Lecturer and the MPharm Programme Director. Her research interests include the in-field detection of NPS, Pharmacy Education and Public Health. Notable applications were accomplished in collaboration with Addaction, where Amira, led on setting up the first UK government-approved Drug-Checking Service within an addiction clinic.

Areas of Expertise

  • Identification and classification of new psychoactive substances
  • New psychoactive substances
  • Drug detection using in-field techniques
  • Raman spectroscopy
  • Drug education
  • Drug checking services
  • Public Health
  • Clinical Pharmacy
  • Education and training of pre-registration pharmacists
  • Chemometrics
  • Analytical Chemistry
  • Drugs of abuse


  1. & Updates on The In-Field Detection of New Psychoactive Substances. Maastricht, The Netherlands.: VI NPS Conference on Novel Psychoactive Substances.
  2. & Method development for the determination of elements in Hypericum perforatum L. (St John's wort) herb and preparations using inductively coupled plasma–optical emission spectroscopy and microwave digestion. Journal of Pharmacy and Pharmacology 71(1), 38-45.
  3. & Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems. Frontiers in Pharmacology 10
  4. & An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions. International Journal of Neuropsychopharmacology 22(4), 270-277.
  5. & New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues. Current Addiction Reports

See more...

Career History

Start Date End Date Position Held Location
March 2019 Present Senior Lecturer and MPharm Programme Director Swansea University Medical School

Key Grants and Projects

  • Drug Checking under a Home Office licence in a substance misuse service 2016

    , with Gittins, R.

  • Assessing Knowledge and Enhancing Detection of Seized Psychoactive Substances in UK Prisons 2018

    , with Stair, J. & Kirton, S

  • A comparative study of the use and impact of cognitive enhancers within Higher Education in the UK and UAE 2018

    , with Fergus, S. & Schifano, F.

  • How do healthcare professionals experience, view and respond to users of new psychoactive substances? 2018

    , with Grierson, J., McBard, L.

Research Groups

Administrative Responsibilities

  • Programme Director, MPharm - Swansea University Medical School

    2019 - Present